432 filings
Page 6 of 22
424B3
flmcg ebctcter
4 Feb 19
Prospectus supplement
5:49pm
6-K
zyxbb7dpr
4 Feb 19
Intellipharmaceutics Appoints New Chief Financial Officer
5:10pm
424B3
qojqmsa3z6cnp 6w0z
28 Jan 19
Prospectus supplement
5:14pm
424B3
9324fr td2k846p9s4e
28 Jan 19
Prospectus supplement
5:11pm
6-K
pfat3908o p1ejqx7
28 Jan 19
Intellipharmaceutics Receives Extension from Nasdaq Hearings Panel
5:06pm
424B3
8kh1a
7 Jan 19
Prospectus supplement
8:17am
424B3
7en8k u7ukh
7 Jan 19
Prospectus supplement
8:14am
6-K
tra5zj
7 Jan 19
Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products
8:09am
424B3
ouffze
6 Dec 18
Prospectus supplement
11:17am
424B3
xkm23
6 Dec 18
Prospectus supplement
11:12am
6-K
4n25c6ij2cb
5 Dec 18
Primary Document
12:00am
424B3
zj3poanuz77w23 n9
28 Nov 18
Prospectus supplement
2:42pm
424B3
73c 5s06gh2d6
28 Nov 18
Prospectus supplement
2:39pm
6-K
80tth45u
27 Nov 18
Intellipharmaceutics Announces FDA Final Approval of Generic Effexor® XR
5:14pm
424B3
7hcz3v5a11poa
27 Nov 18
Prospectus supplement
3:36pm
424B3
fqmd00qawpbn
27 Nov 18
Prospectus supplement
3:22pm
424B3
9dtl5qnhp3dy2xi5 xy4
27 Nov 18
Prospectus supplement
3:18pm
424B3
4m0m1q7xocp6oe
27 Nov 18
Prospectus supplement
3:15pm
6-K
9q0rwg1
27 Nov 18
Primary Document
8:10am
6-K
shtj1pw9
26 Nov 18
Intellipharmaceutics Announces Receipt of Nasdaq Notice
9:37pm